Zia-Amirhosseini P - Search Results

1

Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in monkeys.

Zia-Amirhosseini P, Minthorn E, Benincosa LJ, Hart TK, Hottenstein CS, Tobia LA, Davis CB. Zia-Amirhosseini P, et al. J Pharmacol Exp Ther. 1999 Dec;291(3):1060-7. J Pharmacol Exp Ther. 1999. PMID: 10565825

2

Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.

Hart TK, Cook RM, Zia-Amirhosseini P, Minthorn E, Sellers TS, Maleeff BE, Eustis S, Schwartz LW, Tsui P, Appelbaum ER, Martin EC, Bugelski PJ, Herzyk DJ. Hart TK, et al. Among authors: zia amirhosseini p. J Allergy Clin Immunol. 2001 Aug;108(2):250-7. doi: 10.1067/mai.2001.116576. J Allergy Clin Immunol. 2001. PMID: 11496242

3

Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma.

Hart TK, Blackburn MN, Brigham-Burke M, Dede K, Al-Mahdi N, Zia-Amirhosseini P, Cook RM. Hart TK, et al. Among authors: zia amirhosseini p. Clin Exp Immunol. 2002 Oct;130(1):93-100. doi: 10.1046/j.1365-2249.2002.01973.x. Clin Exp Immunol. 2002. PMID: 12296858 Free PMC article.

4

Pharmacokinetics of a hematoregulatory peptide (SK&F107647) in healthy male volunteers and in patients with colorectal or pancreatic adenocarcinoma not amenable to standard therapy.

Zia-Amirhosseini P, Harris RZ, Cowley HC, Valle JW, Citerone DR, Boppana VK, Scarffe H, Watson P, Davis CB. Zia-Amirhosseini P, et al. Pharm Res. 2000 Apr;17(4):385-90. doi: 10.1023/a:1007512617139. Pharm Res. 2000. PMID: 10870980

5

Pharmacokinetics, pharmacodynamics, and safety assessment of palifermin (rHuKGF) in healthy volunteers.

Zia-Amirhosseini P, Salfi M, Leese P, Yates W, Danilenko DM, Ring B, Cesano A, Sullivan JT. Zia-Amirhosseini P, et al. Clin Pharmacol Ther. 2006 Jun;79(6):558-69. doi: 10.1016/j.clpt.2006.02.011. Clin Pharmacol Ther. 2006. PMID: 16765144 Clinical Trial.

6

Pharmacokinetics of palifermin administered as the standard dose and as a collapsed dose in patients with hematologic malignancies.

Zia-Amirhosseini P, Hurd DD, Salfi M, Cheah TC, Aycock J, Cesano A. Zia-Amirhosseini P, et al. Pharmacotherapy. 2007 Oct;27(10):1353-60. doi: 10.1592/phco.27.10.1353. Pharmacotherapy. 2007. PMID: 17896890 Clinical Trial.

7

Effect of renal function on the pharmacokinetics of palifermin.

Gillespie B, Zia-Amirhosseini P, Salfi M, Kakkar T, Wang J, Gupta S, Smith B, Robson R, Sullivan JT. Gillespie B, et al. Among authors: zia amirhosseini p. J Clin Pharmacol. 2006 Dec;46(12):1460-8. doi: 10.1177/0091270006292705. J Clin Pharmacol. 2006. PMID: 17101745 Clinical Trial.

8

Enhanced covalent binding of tolmetin to proteins in humans after multiple dosing.

Zia-Amirhosseini P, Ojingwa JC, Spahn-Langguth H, McDonagh AF, Benet LZ. Zia-Amirhosseini P, et al. Clin Pharmacol Ther. 1994 Jan;55(1):21-7. doi: 10.1038/clpt.1994.5. Clin Pharmacol Ther. 1994. PMID: 8299313

9

Hypersensitivity to nonsteroidal anti-inflammatory drugs.

Zia-Amirhosseini PZ, Harris RZ, Brodsky FM, Benet LZ. Zia-Amirhosseini PZ, et al. Nat Med. 1995 Jan;1(1):2-4. doi: 10.1038/nm0195-2b. Nat Med. 1995. PMID: 7584944 No abstract available.

10

Basic principles of pharmacokinetics.

Benet LZ, Zia-Amirhosseini P. Benet LZ, et al. Toxicol Pathol. 1995 Mar-Apr;23(2):115-23. doi: 10.1177/019262339502300203. Toxicol Pathol. 1995. PMID: 7569664 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters